In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems - Université de Bretagne Occidentale Accéder directement au contenu
Article Dans Une Revue Thrombosis Research Année : 2018

In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems

Domaines

Sciences du Vivant [q-bio] Médecine humaine et pathologie Ingénierie biomédicale Médecine nucléaire

Ghislaine Calvez  : Connectez-vous pour contacter le contributeur

https://hal.univ-brest.fr/hal-02057877

Soumis le : mardi 5 mars 2019-16:23:57

Dernière modification le : jeudi 18 avril 2024-16:26:16

Fichier non déposé

Dates et versions

hal-02057877 , version 1 (05-03-2019)

Identifiants

Citer

Philippe Robin, Srishti Kumar, Pierre-Yves Salaun, Pierre-Yves Le Roux, Francis Couturaud, et al.. In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems. Thrombosis Research, 2018, 171, pp.97-102. ⟨10.1016/j.thromres.2018.09.050⟩. ⟨hal-02057877⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-BREST GETBO USPC IBSAM UP-SANTE
30 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More